Akero Therapeutics (AKRO) Revenue & Revenue Breakdown
Akero Therapeutics Revenue Highlights
00
Akero Therapeutics Revenue by Period
Akero Therapeutics Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2019-12-31 | - | 100.00% |
2018-12-31 | - | - |
Akero Therapeutics Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-09-30 | - | 100.00% |
2024-06-30 | - | 100.00% |
2024-03-31 | - | -100.00% |
2023-12-31 | $284.00K | 100.00% |
2023-09-30 | - | 100.00% |
2023-06-30 | - | 100.00% |
2023-03-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | 100.00% |
2022-03-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2021-09-30 | - | 100.00% |
2021-06-30 | - | 100.00% |
2021-03-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2020-09-30 | - | 100.00% |
2020-06-30 | - | 100.00% |
2020-03-31 | - | 100.00% |
2019-12-31 | - | 100.00% |
2019-09-30 | - | 100.00% |
2019-06-30 | - | 100.00% |
2019-03-31 | - | 100.00% |
2018-12-31 | - | 100.00% |
2018-09-30 | - | 100.00% |
2018-06-30 | - | 100.00% |
2018-03-31 | - | 100.00% |
2017-12-31 | - | - |
Akero Therapeutics Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
PTGX | Protagonist Therapeutics | $60.00M | $4.67M |
RVMD | Revolution Medicines, Inc. Warrant | $11.58M | - |
RNA | Avidity Biosciences | $9.56M | $2.04M |
STOK | Stoke Therapeutics | $8.78M | $4.89M |
BCEL | Atreca | $770.00K | $80.00K |
BDTX | Black Diamond Therapeutics | - | - |
VKTX | Viking Therapeutics | - | - |
INZY | Inozyme Pharma | - | - |
MDGL | Madrigal Pharmaceuticals | - | $62.17M |
PASG | Passage Bio | - | - |
TERN | Terns Pharmaceuticals | - | - |
AKRO | Akero Therapeutics | - | - |